306 related articles for article (PubMed ID: 25006439)
1. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).
Maron BA; Leopold JA
Pulm Circ; 2014 Jun; 4(2):200-10. PubMed ID: 25006439
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.
Maron BA; Zhang YY; White K; Chan SY; Handy DE; Mahoney CE; Loscalzo J; Leopold JA
Circulation; 2012 Aug; 126(8):963-74. PubMed ID: 22787113
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.
de Man FS; Tu L; Handoko ML; Rain S; Ruiter G; François C; Schalij I; Dorfmüller P; Simonneau G; Fadel E; Perros F; Boonstra A; Postmus PE; van der Velden J; Vonk-Noordegraaf A; Humbert M; Eddahibi S; Guignabert C
Am J Respir Crit Care Med; 2012 Oct; 186(8):780-9. PubMed ID: 22859525
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.
Aghamohammadzadeh R; Zhang YY; Stephens TE; Arons E; Zaman P; Polach KJ; Matar M; Yung LM; Yu PB; Bowman FP; Opotowsky AR; Waxman AB; Loscalzo J; Leopold JA; Maron BA
FASEB J; 2016 Jul; 30(7):2511-27. PubMed ID: 27006450
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone and Mineralocorticoid Receptor Antagonists on Pulmonary Hypertension and Right Ventricular Failure: A Review.
Omidkhoda N; Vakilian F; Mohammadpour AH; Sathyapalan T; Sahebkar A
Curr Pharm Des; 2020; 26(31):3862-3870. PubMed ID: 32445449
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
[TBL] [Abstract][Full Text] [Related]
10. Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.
Ameri P; Bertero E; Meliota G; Cheli M; Canepa M; Brunelli C; Balbi M
Heart Fail Rev; 2016 Sep; 21(5):539-47. PubMed ID: 27206576
[TBL] [Abstract][Full Text] [Related]
11. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
Duprez DA
J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone Contributed to Pulmonary Arterial Hypertension Development via Stimulating Aquaporin Expression and Pulmonary Arterial Smooth Muscle Cells Proliferation.
Wang Y; Zhong B; Wu Q; Zhu T; Wang Y; Zhang M
Pharmacology; 2020; 105(7-8):405-415. PubMed ID: 31995798
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.
Preston IR; Sagliani KD; Warburton RR; Hill NS; Fanburg BL; Jaffe IZ
Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(10):L678-88. PubMed ID: 23457185
[TBL] [Abstract][Full Text] [Related]
14. Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
Boehm M; Arnold N; Braithwaite A; Pickworth J; Lu C; Novoyatleva T; Kiely DG; Grimminger F; Ghofrani HA; Weissmann N; Seeger W; Lawrie A; Schermuly RT; Kojonazarov B
BMC Pulm Med; 2018 Mar; 18(1):41. PubMed ID: 29499691
[TBL] [Abstract][Full Text] [Related]
15. Role of intracardiac renin-angiotensin-aldosterone system in extracellular matrix remodeling.
Lijnen PJ; Petrov VV
Methods Find Exp Clin Pharmacol; 2003 Sep; 25(7):541-64. PubMed ID: 14571285
[TBL] [Abstract][Full Text] [Related]
16. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L
Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
Hirono Y; Yoshimoto T; Suzuki N; Sugiyama T; Sakurada M; Takai S; Kobayashi N; Shichiri M; Hirata Y
Endocrinology; 2007 Apr; 148(4):1688-96. PubMed ID: 17218415
[TBL] [Abstract][Full Text] [Related]
18. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats.
Tu L; Thuillet R; Perrot J; Ottaviani M; Ponsardin E; Kolkhof P; Humbert M; Viengchareun S; Lombès M; Guignabert C
Hypertension; 2022 Oct; 79(10):2262-2273. PubMed ID: 35979822
[TBL] [Abstract][Full Text] [Related]
20. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
Chang H; Chang CY; Lee HJ; Chou CY; Chou TC
Phytomedicine; 2018 Dec; 51():205-213. PubMed ID: 30466619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
